Less hype and more research needed into new 'superbug,' say experts

Jun 13, 2008

Recent tabloid hype over the "newly emerging superbug", Stenotrophomonas maltophilia, is misplaced, say experts in this week's issue of the BMJ.

Headlines about S maltophilia including "no antibiotics can stop it" and "rising death toll in hospitals" are unfounded, write Georgia Duckworth and Alan Johnson, from the Health Protection Agency's Centre for Infections in London. In fact, they say, S maltophilia infections are relatively rare compared to infections caused by other species of viruses and bacteria such as Staphylococcus aureus (MRSA).

Despite recent concerns, S maltophilia accounts for less than 1% of all bloodstream infections in England and Wales. Data from the Health Protection Agency in 2007 shows that in England, 4918 cases of bloodstream infection were caused by MRSA compared with 671 by S maltophilia, while Clostridium difficle caused over 50 000 cases of gastrointestinal infections.

Indeed, S maltophilia infections are uncommon in previously healthy patients, are not easily spread, and are usually treatable, say the authors, in contrast to MRSA and C difficile which can be difficult to treat and have epidemic potential.

The authors suggest that the organism is, in reality, more deserving of the 'opportunist' rather than the 'superbug' label.

They point out that because it is relatively uncommon and treatable, it is unlikely that large scale interventions will be aimed specifically at S maltophilia, but interventions such as improved hospital hygiene and antibiotic stewardship will help prevent its spread and the emergence of multi-resistance.

"We hope that this new knowledge of the organism's biology will help allay these [recent] concerns by being used to improve diagnostic tests, identify new drug targets, or even develop a vaccine", conclude the authors.

Source: BMJ

Explore further: Chikungunya fever identified in the United States

add to favorites email to friend print save as pdf

Related Stories

Plant microbe shares features with drug-resistant pathogen

Jun 16, 2009

An international team of scientists has discovered extensive similarities between a strain of bacteria commonly associated with plants and one increasingly linked to opportunistic infections in hospital patients. The findings ...

Superbug genome sequenced

May 07, 2008

The genome of a newly-emerging superbug, commonly known as Steno, has just been sequenced. The results reveal an organism with a remarkable capacity for drug resistance. The research was carried out by scientists ...

Recommended for you

Chikungunya fever identified in the United States

4 hours ago

(HealthDay)—Chikungunya fever is being seen in travelers returning to the United States from affected regions and should be considered as a diagnosis for febrile travelers, according to an ideas and opinions ...

Boost in quest for TB breath test

7 hours ago

A simple breath test may one day show whether someone has a strain of tuberculosis that will respond to a frontline antibiotic, or a drug-resistant type, scientists said Tuesday.

Three more dead from Legionnaire's disease in Spain

7 hours ago

Three more people have died from Legionnaire's disease in Catalonia in northeastern Spain, officials said Tuesday, bringing to seven the death toll from the lung infection in the region in just over a week.

User comments : 0